340B is not the driver of high drug prices. The pharmaceutical corporations' unlimited power to set the list price is the driver.
Janice Schakowsky: “340B is not the driver of high drug prices. The pharmaceutical corporations' unlimited power to set the list price is…”
On the recordJuly 10, 2018
Source
congress.govEditor's note · Context
Schakowsky argues that pharmaceutical companies, not the 340B program, are responsible for high drug prices.
Share
More from Janice Schakowsky
May 27, 2026
Let’s be clear: Medicare Advantage is not Medicare. These private insurance plans use Medicare’s trusted name while too often denying medically necessary care, restricting providers, and overcharging taxpayers by billions. That is…
May 27, 2026
Abandoning that approach in favor of reckless escalation puts lives, security, and regional stability at risk.
May 28, 2026
‘Do not call’ means do not call. Period. But illegitimate and intrusive robocalls are only getting worse, especially as scammers weaponize AI to impersonate loved ones and exploit Americans. So many of us are bombarded with relentless…





